Keratin expression in human tissues and neoplasms
PG Chu, LM Weiss - Histopathology, 2002 - Wiley Online Library
Keratin expression in human tissues and neoplasms Keratin filaments constitute type I and
type II intermediate filaments (IFs), with at least 20 subtypes named keratin 1–20. Since …
type II intermediate filaments (IFs), with at least 20 subtypes named keratin 1–20. Since …
Pathogenetic mechanisms in thyroid follicular-cell neoplasia
Thyroid cancer is one of the few malignancies that are increasing in incidence. Recent
advances have improved our understanding of its pathogenesis; these include the …
advances have improved our understanding of its pathogenesis; these include the …
[图书][B] Pathology and genetics of tumours of endocrine organs
RA DeLellis - 2004 - books.google.com
This volume covers tumors of the pituary, the thyroid and parathyroid, the adrenal gland, the
endocrine pancreas, and inherited tumor syndromes. Each entity is extensively discussed …
endocrine pancreas, and inherited tumor syndromes. Each entity is extensively discussed …
RAS Point Mutations and PAX8-PPARγ Rearrangement in Thyroid Tumors: Evidence for Distinct Molecular Pathways in Thyroid Follicular Carcinoma
MN Nikiforova, RA Lynch, PW Biddinger… - The Journal of …, 2003 - academic.oup.com
A series of 88 conventional follicular and Hürthle cell thyroid tumors were analyzed for
RAS mutations and PAX8-PPARγ rearrangements using molecular methods and for galectin …
RAS mutations and PAX8-PPARγ rearrangements using molecular methods and for galectin …
RET/PTC rearrangement in thyroid tumors
YE Nikiforov - Endocrine pathology, 2002 - Springer
Rearrangement of the RET gene, also known as RET/PTC rearrangement, is the most
common genetic alteration identified to date in thyroid papillary carcinomas. The prevalence …
common genetic alteration identified to date in thyroid papillary carcinomas. The prevalence …
Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma
TM Elsheikh, SL Asa, JKC Chan… - American journal of …, 2008 - academic.oup.com
Distinguishing follicular variant of papillary carcinoma (FVPC) from follicular adenoma and
follicular carcinoma can be difficult if nuclear features of papillary carcinoma are not well …
follicular carcinoma can be difficult if nuclear features of papillary carcinoma are not well …
Gene expression in papillary thyroid carcinoma reveals highly consistent profiles
Y Huang, M Prasad, WJ Lemon… - Proceedings of the …, 2001 - National Acad Sciences
Papillary thyroid carcinoma (PTC) is clinically heterogeneous. Apart from an association with
ionizing radiation, the etiology and molecular biology of PTC is poorly understood. We used …
ionizing radiation, the etiology and molecular biology of PTC is poorly understood. We used …
[HTML][HTML] Galectin-3, fibronectin-1, CITED-1, HBME1 and cytokeratin-19 immunohistochemistry is useful for the differential diagnosis of thyroid tumors
ML Prasad, NS Pellegata, Y Huang, HN Nagaraja… - Modern pathology, 2005 - Elsevier
The diagnosis of thyroid tumors is critical for clinical management; however, tumors with
follicular architecture often present problems. We evaluated the diagnostic use of the protein …
follicular architecture often present problems. We evaluated the diagnostic use of the protein …
TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis
TERT reactivation occurs frequently in human malignancies, especially advanced cancers.
However, in vivo functions of TERT reactivation in cancer progression and the underlying …
However, in vivo functions of TERT reactivation in cancer progression and the underlying …
Usefulness of HBME‐1, cytokeratin 19 and galectin‐3 immunostaining in the diagnosis of thyroid malignancy
PS De Matos, AP Ferreira, F de Oliveira Facuri… - …, 2005 - Wiley Online Library
Aims: To investigate the usefulness of immunohistochemical expression and
immunolocalization of a panel of thyroid malignancy markers including HBME‐1, cytokeratin …
immunolocalization of a panel of thyroid malignancy markers including HBME‐1, cytokeratin …